NEW YORK (GenomeWeb News) – Transposagen Biopharmaceuticals, a privately held firm making animal models of human disease for research purposes, today said that it has been approved for a $325,000 forgivable loan from the Kentucky High-Tech Investment Pool.
 
Lexington, Ky.-based Transposagen said that it will use the funding to purchase lab equipment and to “obtain protection” for its intellectual property.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.